- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Plasma Homocysteine in New Zealand
Total 880 results
-
Yale UniversityCompletedMultiple Myeloma | Influenza | Waldenstrom's Macroglobulinemia | MGUS | Plasma Cell DisordersUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | Metastatic Malignant Neoplasm in the Bone | Bone PainUnited States
-
Aronex PharmaceuticalsCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Infection | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Icahn School of Medicine at Mount SinaiMillennium Pharmaceuticals, Inc.CompletedAL AmyloidosisUnited States
-
Andrew EisenbergerCompletedAmyloidosisUnited States
-
Regeneron PharmaceuticalsRecruiting
-
SanofiCompletedPlasma Cell MyelomaUnited States
-
Icahn School of Medicine at Mount SinaiMemorial Sloan Kettering Cancer Center; Hackensack Meridian HealthCompletedFatigue | Multiple MyelomaUnited States
-
Rajshekhar Chakraborty, MDGenentech, Inc.RecruitingAL AmyloidosisUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingIdasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaRecurrent Plasma Cell Myeloma | Loss of Chromosome 17pUnited States
-
PfizerBristol-Myers SquibbRecruiting
-
Geron CorporationCompletedMultiple MyelomaUnited States
-
Infinity Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
AllerganCompletedPlatysma ProminenceUnited States, Canada
-
AllerganCompletedPlatysma ProminenceUnited States, Canada
-
SanofiCompletedPlasma Cell MyelomaFrance, Spain, Greece, Korea, Republic of, United States, Australia, Belgium, Canada, Czechia, Denmark, Germany, Hungary, Italy, Japan, New Zealand, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden, Taiwan, Turkey, United...
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncWithdrawnAL Amyloidosis | Amyloidosis | AmyloidUnited States
-
SanofiRecruitingPlasma Cell Myeloma RecurrentUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Czechia, France, Germany, Greece, Hungary, Italy, Japan, Norway, Poland, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Weill Medical College of Cornell UniversityOnyx Therapeutics, Inc.Active, not recruiting
-
Weill Medical College of Cornell UniversityCelgeneActive, not recruiting
-
Icahn School of Medicine at Mount SinaiBristol-Myers Squibb; Multiple Myeloma Research ConsortiumEnrolling by invitation
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterOtsuka America Pharmaceutical; Ludwig Institute for Cancer ResearchCompleted
-
Weill Medical College of Cornell UniversityCelgene CorporationCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityPfizer; Celgene CorporationTerminatedMultiple MyelomaUnited States
-
Sundar JagannathBristol-Myers SquibbNo longer available
-
Roswell Park Cancer InstituteCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Fanconi Anemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Aplastic AnemiaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsRecruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Not yet recruiting
-
PfizerCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyActive, not recruitingMultiple MyelomaUnited States
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Multiple Myeloma Research...TerminatedPhase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell TransplantMultiple MyelomaUnited States
-
Ajai ChariTerminatedMultiple MyelomaUnited States
-
Columbia UniversityCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgeneTerminated
-
NYU Langone HealthCelgeneTerminatedMultiple MyelomaUnited States
-
SanofiCompletedPlasma Cell MyelomaFrance, Italy, Czechia, Greece, Spain, Canada, Australia, United States, Brazil, Hungary
-
Memorial Sloan Kettering Cancer CenterVanderbilt University Medical Center; Tufts Medical CenterActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterTrillium Therapeutics Inc.Active, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
PfizerCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgeneCompletedMultiple MyelomaUnited States